86 results
Page 2 of 5
F-3
7vb e5jnr2r7q2fdz6
17 Feb 22
Shelf registration (foreign)
4:14pm
F-3
EX-4.1
mdq96y0mrqipifrsg
17 Feb 22
Shelf registration (foreign)
4:14pm
F-3
k7qx wppanv6os88f8d
17 Feb 22
Shelf registration (foreign)
4:14pm
6-K
EX-99.3
j2rq phedk
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
424B7
kl1lq1zz1wjf86un pu4
23 Nov 21
Prospectus with selling stockholder info
4:06pm
F-3
EX-5.1
ndu 75wpmbqouz1tju
10 Nov 21
Shelf registration (foreign)
5:23pm
F-3
7wr3afiio
10 Nov 21
Shelf registration (foreign)
5:23pm
6-K/A
EX-99.1
q69pdqnrg7wsck
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K/A
EX-99.2
6lin7lpop 3h
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K/A
EX-99.5
m91gwq
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
gimqk1ezw a6f
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.1
bnd s88g5iab
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.5
9velc
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.1
oa03ez6ge28yebvkzj
22 Apr 21
ObsEva Annual General Meeting 2021
6:31am
6-K
EX-1.1
xbzc65pljt m3
5 Mar 21
Current report (foreign)
8:15am
6-K
EX-5.1
43wcq2l4zv 8r
5 Mar 21
Current report (foreign)
8:15am
424B5
wk5nv6v
5 Mar 21
Prospectus supplement for primary offering
7:55am